Healthcare provider profile · identity verified

Ainun Haq, M.D

Internal Medicine · NORTH GRAFTON, MA · NPI 1063698322

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	600	163
Lisinopril	Lisinopril	385	101
Amlodipine Besylate	Amlodipine Besylate	256	58
Levothyroxine Sodium	Levothyroxine Sodium	248	53
Trazodone Hcl	Trazodone Hcl	227	30
Omeprazole	Omeprazole	226	52
Metoprolol Succinate	Metoprolol Succinate	174	40
Gabapentin	Gabapentin	164	41
Eliquis	Apixaban	151	25
Metformin Hcl	Metformin Hcl	150	41
Sertraline Hcl	Sertraline Hcl	147	29
Simvastatin	Simvastatin	133	31
Hydrochlorothiazide	Hydrochlorothiazide	128	37
Lorazepam	Lorazepam	127	33
Losartan Potassium	Losartan Potassium	118	34
Potassium Chloride	Potassium Chloride	93	24
Tamsulosin Hcl	Tamsulosin Hcl	93	18
Rosuvastatin Calcium	Rosuvastatin Calcium	91	31
Olanzapine	Olanzapine	89	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	88	26
Furosemide	Furosemide	84	28
Benztropine Mesylate	Benztropine Mesylate	74	suppressed
Oxycodone Hcl	Oxycodone Hcl	74	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	14
Quetiapine Fumarate	Quetiapine Fumarate	62	suppressed
Famotidine	Famotidine	61	20
Mirtazapine	Mirtazapine	60	13
Clonazepam	Clonazepam	58	12
Atenolol	Atenolol	57	17
Metoprolol Tartrate	Metoprolol Tartrate	56	14
Venlafaxine Hcl Er	Venlafaxine Hcl	56	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Ibuprofen	Ibuprofen	54	12
Prazosin Hcl	Prazosin Hcl	53	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	52	13
Paroxetine Hcl	Paroxetine Hcl	52	suppressed
Valsartan	Valsartan	50	13
Meclizine Hcl	Meclizine Hcl	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	44	14
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Topiramate	Topiramate	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	32
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Ezetimibe	Ezetimibe	32	13
Bupropion Xl	Bupropion Hcl	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Amantadine	Amantadine Hcl	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	13
Prednisone	Prednisone	29	14
Trulicity	Dulaglutide	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	28	suppressed
Invega Sustenna	Paliperidone Palmitate	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Glipizide	Glipizide	27	suppressed
Divalproex Sodium Er	Divalproex Sodium	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Labetalol Hcl	Labetalol Hcl	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Bupropion Hcl	Bupropion Hcl	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	20
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Finasteride	Finasteride	23	suppressed
Lactulose	Lactulose	23	suppressed
Perphenazine	Perphenazine	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Loperamide	Loperamide Hcl	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Nystatin	Nystatin	20	suppressed
Cephalexin	Cephalexin	19	17
Jardiance	Empagliflozin	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Risperidone	Risperidone	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	14
Metformin Hcl Er	Metformin Hcl	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Alprazolam	Alprazolam	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Ozempic	Semaglutide	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Desmopressin Acetate	Desmopressin Acetate	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Praluent Pen	Alirocumab	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sirolimus	Sirolimus	12	suppressed
Torsemide	Torsemide	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	11
Gemfibrozil	Gemfibrozil	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Paliperidone Er	Paliperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error